← Contracts
PT
1364/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de, R1100 - RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA], R1101 - RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA]
ID 11383046
· Portal BASE
Price
Base Price
€1,597,844
.00
Effective Price
€111,495
.00
-93.0%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Porto, Santo Tirso Portugal, Braga, Vila Nova de Famalicão
- Bidder Count
- —
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Dates
- Publication
- 28 Apr 2025
- Celebration
- 20 Feb 2025
Contracting Entity
Unidade Local de Saúde do Médio Ave, E.P.E.
NIF 508093937
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 28 Apr 2025
- Signing Date
- 20 Feb 2025
- Days Late
- 67
- Rule
- A2/A3 late publication: 67 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 1597844.0
- Total effective price
- 111495.0
- Ratio
- 0.0698
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0698 outside [0.5, 1.5]
Detected 2026-03-06